Elucid Bioimaging receives Phase IIB Bridge Award

May 15, 2019

Elucid Bioimaging, Inc. today announced that that it has been awarded a highly-competitive Phase IIB Bridge Award from the National Heart, Lung, and Blood Institute of the NIH for its atherosclerosis evaluation software vascuCAP®. The competitive review criteria for considering grant applications under this program include scientific merit, clinical utility, and strength of the commercialization plan.

Read the Full Release Here